InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Francois Cedric, Chief Executive Officer. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 9 filings have been logged. The latest transaction was disclosed on 10 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
425,968 shares
Common Stock
SEC:0001193125-26-224579·
425,968 shares
Common Stock
SEC:0001193125-26-224579:0·
€104,0872,523 shares@ €41.25540.0020% mcap29.8% of flow
Common Stock
SEC:0001127602-22-004907:0·
€70,0692,024 shares@ €34.61910.0013% mcap57.1% of flow
Common Stock
SEC:0001127602-22-002806·
€70,0692,024 shares@ €34.61910.0013% mcap20.0% of flow
Common Stock
SEC:0001127602-22-002806:0·
0106,244 shares0
Common Stock
SEC:0001127602-22-002069·
0106,244 shares0
Common Stock
SEC:0001127602-22-002069:0·
€52,66614,410 shares@ €3.65480.0010% mcap42.9% of flow
Common Stock
SEC:0001127602-21-022370·
€52,66614,410 shares@ €3.65480.0010% mcap15.1% of flow
Common Stock
SEC:0001127602-21-022370:0·
9 of 9 declarations
About Francois Cedric
Cedric Francois is the Chief Executive Officer of Apellis Pharmaceuticals, Inc. He leads the company's strategic operations and ensures the implementation of growth objectives. His industry experience enables him to make informed decisions that promote the long-term success of Apellis.
